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Summary.-Effects ofthe mitotic inhibitor NY3170(1-propargyl-5-chloropyrimidin-
2-one) on cell-cycle kinetics of NHIK 3025 cells were studied by means of time-lapse
microcinematography, pulsed incorporation of [3H] thymidine, flow cytometry, and
mitotic index. Allthe experiments were performed with cells synchronized by mitotic
selection.
Mitotic inhibition as well as inhibition in interphase was examined. The small
fraction of cells able to escape mitotic arrest at 0.2mM NY 3170 had spent about 12 h
in metaphase. The metaphase block was complete at 0 3 mm. For comparison, com-
plete metaphase arrest of NHIK3025 cells was reached at 8 mm after treatment with
the parent substance NY 3000 (5-chloropyrimidin-2-one, previously reported).
At 0-3mM NY 3170 interphase was also considerably prolonged. All stages of inter-
phase were prolonged, in contrast to theinterphase prolongation after treatment with
high concentrations ofthe mitotic inhibitors vincristine and vinblastine, which occurs
in G2.
It was shown that the presence of NY 3170 during mitosis is a necessary and
sufficient condition for metaphase arrest, thus demonstrating that metaphase arrest
is not dependent on some preceding event in interphase.
THE MITOTIC INHIBITORS vincristine
and vinblastine are extensively used in
cancer chemotherapy. However, severe
side-effects of the Vinca alkaloids in the
body present a limitation to the clinical
efficiency of these drugs (Winkelman &
Mancall, 1972). Therefore, efforts are
being made to develop new drugs which
demonstrate similar inhibitory effects on
malignant cells, but less side effects on
normal body tissue.
Previous reports from our laboratory
(Oftebro et al., 1972; Wibe et al., 1978)
described inhibitory effects of the new
mitotic inhibitors 5-fluoropyrimidin-2-one
and 5-chloropyrimidin-2-one (NY 3000).
The effects of NY 3000 on cell-cycle
kinetics inNHIK 3025 cellswere compared
with the effects of vincristine (Wibe et al.,
1978).
In the present investigation another
new drug, NY 3170, which is a chemical
modification of NY 3000 (see Fig. 1), also
proved to be a mitotic inhibitor, but at
considerably lower molar concentrations
than NY 3000.
MATERIALS AND METHODS
NY 3170.-The chemical structure of NY
3170 is shown in Fig. 1. The substance was
synthesized at the Department ofChemistry,
Blindern, University of Oslo, by Drs M.
Gacek and K. Undheim, and belongs to a
new group of metaphase inhibitors for which
the name metahalones is suggested (Gacek et
al., submitted).
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FIG. 1.-Chemical structure of NY 3170 (1-
propargyl -5 -chloropyrimidin -2 - one) and
NY 3000 (5-chloropyrimidin-2-one).
NY 3170 was dissolved in culture medium,
and the drug solution was sterilized by milli-
pore filtration before use.
Cell culture.-The cell line NHIK 3025
originates from a human cervix carcinoma in
8itU (Nordbye & Oftebro, 1969; Oftebro &
Nordbye, 1969).
The culture medium used was E2a (Puck
et al., 1957) with40% synthetic mixture, 30%
Hanks' solution, 20% human serum, and 10%
horse serum. Stock cultures were grown in
75-cm2 Nunclon flasks (A/S Nunc, Roskilde,
Denmark) and trypsinized 3 times weekly to
maintain optimal growth conditions.
Synchronized cell populations were ob-
tained by mitotic shake-offtechnique (Petter-
sen et al., 1977).
Time-lap8e microcinematography.-The ex-
perimental procedure of the time-lapse ex-
periments has been described in detail in a
previous paper (Wibe et al., 1978), so is only
summarized here.
Selected mitotic cells were allowed to
attach to coverslips located at the bottom of
2 Petri dishes. Two hours after selection, i.e.
in early G1, the test population received
medium containing NY 3170, while the con-
trol population received fresh medium. Four
hours later, the coverslips were transferred to
Emdeco Model 101-700 tissue-culture cham-
bers and supplied with medium from the
Petri dishes.
In the present experiments, the interval
between each picture was 8 min, and filming
was stopped 48 h after selection. As described
previously (Wibe et al., 1978) the duration of
mitosis for each cell was measured as the
interval between the moment when the cell
had assumed a circular outline and the time
of appearance of daughter cells, each with
unbroken contours. The average duration of
mitosis measured this way in different experi-
ments was 30-40 min for control populations.
In calculating the average duration of
interphase or mitosis for each population, the
fastest and the slowest 10% ofthe population
were omitted.
Determination of phase durations.-Newly
selected mitotic cells were plated in 25-cm2
Nunclon flasks (5 ml cell suspension perflask).
At appointed times the drug was added or
removed by change of medium.
The rate of DNA synthesis (showing onset
and duration of S) was measured at regular
intervals during the cell cycle by pulsed
[3H]TdR incorporation. The pulse-labelling
technique (15min pulse; 1 ,uCi/ml medium;
5 Ci/mmol) has been described earlier
(Pettersen et al., 1977).
In parallel populations the onset of the
first mitosis after selection was registered for
individual cells in a microscope (demon-
strating the duration of interphase). At least
100 cells in each population were scored.
Thus, knowing the total duration of inter-
phase and the position and duration of S, the
duration of G1 and G2 could also be deter-
mined for each population (Pettersen et al.,
1977). The average durations ofG1, S, G2 and
mitosis for untreated NHIK 3025 cells grown
in medium E2a, are 6-5, 8, 2-5 and 1 h
respectively (Pettersen et al., 1977).
Flow cytometry.-At set times after mitotic
selection, cells were harvested and stained
(without previous fixation) with the DNA-
specific fluorescent stain mithramycin (100
jug/ml) (Charles Pfizer & Co., Inc., New York,
N.Y.) according to the method ofCrissman &
Tobey (1974). DNA histograms were recorded
by means of a laboratory-built flow cyto-
meter (Lindmo & Steen, 1977) with excitation
light of wavelength 457 nm and fluorescence
detection atwavelengths greaterthan476nm.
Mitotic index.-Selected mitotic cells were
plated in 25-cm Nunclon flasks immediately
after synchronization. The cells were exposed
to 0-2mM NY 3170 for 3 h in different stages
of interphase. On removal of medium con-
taining NY 3170, the flasks were rinsed once
with fresh medium before reincubation. In
one flask, NY 3170 was added 15 h after
selection (in G2) and not removed.
From 14 h after selection the mitotic index
(100 xnumber of mitotic cells/total number
of counted cells) for each experimental group
was recorded at short intervals in an invertedINHIBITORY EFFECTS OF NY 3170 IN VITRO
phase-contrast microscope. For each estimate
of the mitotic index more than 300 cells were
scored.
RESULTS
Fig. 2 shows the fractions of cells enter-
ing mitosis (Curve b) and escaping mitotic
arrest (Curve a) when NHIK 3025 cells
were subjected to various concentrations
ofNY 3170. The cells were always followed
up to 48 h after mitotic selection in the
time-lapse experiments. Curve b in Fig. 2
indicates that a considerable fraction of
the cells treated with 0 3 or 0 4mM NY
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FIG. 2(a).-Fractions ofNHIK 3025 cells able
to escape mitotic arrest during time of
filming (up to 48 h after mitotic selection)
at different concentrations of NY 3170,
normalized to 100% cell division in control
populations. (b) Fractions of treated cells
able to reach mitosis during time of filming
(0) normalized to 100% for untreated
cells. Each plotted value represents a
separate experiment. The control values
were always between 0-9 and 1-0.
3170 were unable to get through inter-
phase and enter mitosis while the drug
was present in the medium. Cells subjected
to 0-2mM were generally able to enter
mitosis, but most ofthem were blocked in
mitosis. Only about 30% of the cells
treated with 0-2mM were able to escape
mitotic arrest (Fig. 2, Curve a), and even
in these cells cytokinesis was evidently
hampered. Fusion between daughter cells
was common at this concentration. Most
of the cells unable to escape metaphase
arrest disintegrated during the period of
observation. On the other hand, cells
which did not reach mitosis during filming
did not disintegrate, irrespective of NY
3170 concentration.
The curve in Fig. 3 shows how the dura-
tion of mitosis, as measured by the time-
lapse technique, was influenced by the
presence of different concentrations of
NY 3170. The average duration of mitosis
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FIG. 3.-Duration of mitosis for NHIK 3025
cells escaping mitotic arrest after treat-
ment with NY 3170. Each plotted value is
the ratio between average time spent in
mitosis for treated and untreated cells in
the same experiment.
seemed to increase exponentially with drug
dose. The duration of mitosis for the frac-
tion of cells able to escape mitotic arrest
at 0-2mM NY 3170 was more than 20 x
that of control cells. Complete block in
mitosis was reached at 0-3mM.
Fig. 4 shows the duration of interphase
forthe fraction ofcells able to reachmitosis
during filming. At 0-2mM, there was a
significant prolongation of interphase of
about 20%, which was reproduced in the
experiments where the generation times of
cell populations plated in culture flasks
were measured (Fig. 5).
There is some variation between the
data presented in Fig. 4 and the experi-
ments with 0-3 or 0-4mM NY 3170. These
results must be seen in association with
Curve b in Fig. 2, which demonstrates
that a considerable fraction of cells did
not reach mitosis during the period of
observation at these concentrations of
NY 3170. Consequently, NY 3170 at a
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FiG. 4.-Duration of interphase for treated
NHIK 3025 cells able to reach mitosis
during time offilming (48 h) relative to the
duration of interphase for untreated cells
in the same experiment.
concentration of 0-3mM or more interferes
with the normal progression of NHIK
3025 cells through the cell cycle to such a
degree that some variation between experi-
ments is not unexpected.
To find out whether the prolongation
of interphase could be traced to one of
the stages G1, S, or G2 in particular,
experiments including pulsed [3H]TdR
incorporation and registration in a micro-
scope of time of entry into mitosis were
performed (Fig. 5). The curves showing
entry into mitosis demonstrate that cells
exposed to 0 2mM NY 3170 from 2 h after
mitotic selection were about 3 h late in
reaching mitosis. The [3H]TdR-incorpora-
tion curves indicate that these cells were
gradually delayed as they traversed the
different stages of interphase. The rate
of progression of cells treated from 2 h
after selection seemed to be especially
slowed down in the last part of the cell
cycle.
In Fig. 5, curves also show the pro-
gressionthroughinterphase ofcellsexposed
to 0-2mM NY 3170 during only a limited
part of interphase. The interphase pro-
longation of cells treated from 6 h after
selection (late G1) was small compared to
that of cells treated from 2 h after selec-
tion (Fig. 5A). The delay which occurred
when cells were treated in G1 only (2-6 h
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FIG. 5.-Cell-cycle progression of treated and
untreated populations of NHIK 3025 cells.
The amount of incorporated [3H]TdR
(left ordinate, open symbols) measured at
set times after synchronization depicts the
position and duration of S for each popu-
lation. The kinetics ofthe entry into mitosis
(right ordinate, closed symbols) are also
shown for each population.
A and B are separate experiments.
A, ct/min x 10-3 and percentage of cells
having entered metaphase for control cells
(0, 0) and cells treated with 0-2mM NY
3170 from 2 h (A, A) or 6 h (O, *) after
mitotic selection.
B, the symbols (0, *) and (A, A) have
the same meaning as in A. ( x, +) cells
treated with 0-2mM NY 3170 from 2 h to
6 h after mitotic selection.
after selection) was also relatively small
(Fig. 5B).
Fig. 6 shows some of the DNA histo-
grams measured for treated (0-2mM NY
3170 from 2 h after mitotic selection) and
untreated cell populations. Both histo-
grams measured 4 h after synchronization
demonstrate that all cells were in G1,
while the histograms measured 10 and 12 h
after synchronization clearly demonstrate
that the treated cells were delayed. The
18h histograms show that most of the
control cells had divided, while the treated
cells were accumulated in G2-mitosis.
l-~~
~~
0a~~~~~~~~,-aa
- A O /
UA(
:* /
00
2 4 6 8 10 12 14 16 18 20 22 24 26
0
0
0+
9A
IINHIBITORY EFFECTS OF NY 3170 IN VITRO
4 h
!l
I 18
! ih
10h
12 h
18 h
DNA content of the most typical cell)
for each of the histograms is plotted in
Fig. 7. These curves indicate that cells
treated with 0 2mM NY 3170 from 2 h
after selection were about 1 h late in
middle S.
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FIG. 6. DNA histograms for NHIK 3025
cells treated with 0-2mM NY 3170 from 2 h
after mitotic selection (dotted lines) com-
pared to histograms for untreated cells
(continuouis lines). Interval from mitotic
selection is indicated in each figure.
To quantify the delay of DNA replica-
tion as measured by flow cytometry, the
median channel number (indicating the
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FIG. 7. Median channel number in each of
the DNA histograms of NHIK 3025 cells
measured for control populations (0) and
populations treated with 0 2mmu NY 3170
from 2 h after mitotic selection (A). From
the histograms of control populations
measured 16, 18 or 20 h after selection, 2
median channel numbers were calculated,
one for the fraction of cells still in G2-
mitosis (0), and one for the fraction of G]
daughter cells (0).
Figs 5A, 6 andI 7 relate to the same
experiment.
Fig. 8 shows mitotic index as a function
of time in populations treated with 0 2mM
NY 3170 for 3 h in different stages of the
cell cycle. The initial rise of the mitotic-
index curves indicates the time when cells
of the different populations started to
enter mitosis. The interphase prolongation
was greatest for cells treated in G1
(3-6 h), and decreased gradually when
exposure took place later in the cell cycle.
The mitotic-index curves in Fig. 8 also
show thatNHIK 3025 cells arenot arrested
in mitosis by NY 3170 when the drug is
removed before the onset of mitosis. This
can be seen from the fact that in none of
the populations from which NY 3170 was
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FIG. 8.-Mitotic index as a function of time
after mitotic selection for untreated
NHIK 3025 cells (0) and cells treated
with 0-2mM NY 3170 for 3 h in different
stages of interphase. * treated 12-15 h;
O treated 9-12 h; v treated 6-9 h;
A treated 3-6 h. In one additional popula-
tion (0) 0-2mM NY 3170 was added at
15 h (in G2) and not removed. The
mitotic-index curve for this population
does not exceed 80%, owing to disintegra-
tion of arrested mitotic cells.
removed before mitosis did the mitotic
index exceed the maximum for the control
population. However, when NY 3170
was added 15 h after selection (in G2) and
not removed, the accumulation of cells
in metaphase was complete.
Thus, the presence of NY 3170 during
mitosis is a necessary and sufficient con-
dition for metaphase arrest, indicating
that metaphase arrest is not due to some
preceding event in interphase.
The cell-kinetic data reported here do
not give much information about the
mechanism behind the metaphase-arrest-
ing properties of NY 3170. However,
examination under a microscope of cells
fixed and stained while arrested in mitosis
indicated that NY 3170 interferes with the
normal function of the mitotic spindle.
In metaphase-arrested cells, both assemb-
lage of all the chromosomes in one cluster
(ball metaphase) and small chromosome
clusters randomly scattered in the cyto-
plasm were seen.
DISCUSSION
When NHIK 3025 cells were continu-
ously exposed to NY 3170 during inter-
phase, delay mainly occurred in the last
part of the cell cycle. Although there was
a 3h prolongation of interphase following
treatment with 0 2mM NY 3170 from 2 h
after mitotic selection (Fig. 5), the cells
were only 1 h late in mid-S (Fig. 7). The
data presented in Fig. 5 indicate that the
prolongation of interphase is maximal
only when the drug is present throughout
interphase.
When cells were exposed to NY 3170
during a limited part of interphase, the
greatest interphase prolongation was in-
duced after treatment in G1 (Fig. 8).
Treatment in late-S-G2 led to only slight
prolongation of interphase although, as
mentioned above, most of the interphase
prolongation appeared in this part of the
cell cycle when NHIK 3025 cells were
continuously exposed to NY 3170. Thus,
prolongation of interphase, which mainly
appears in the last part of the cell cycle,
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is induced in G1. Probably, events taking
place later in the cycle are not sufficiently
prepared for when NY 3170 is present
in G1.
NY 3170 is evidently more effective
as a mitotic inhibitor than the parent
substance NY 3000 (Wibe et al., 1978)
in respect of the dose range of operation.
Complete metaphase block is achieved at
0-3mM NY 3170, compared to 8mM for
NY 3000 (Wibe et al., 1978). The replace-
ment of the hydrogen atom in the 1
position of NY 3000 with the group con-
taining a triple bond (Fig. 1) has undoubt-
edly strengthened the metaphase-arresting
properties of the drug.
The mode of action, however, seems to
be rather similar for NY 3170 and NY
3000. For both substances the interphase
effect becomes severe at the same con-
centration as the one producing complete
block in metaphase. Moreover, for both
NY 3170 and NY 3000, the interphase
prolongation is not very phase-specific.
The only striking difference between the
mode of action of these 2 substances is
the pronounced dose-dependence of NY
3170, reflected in much steeper dose-
response curves (Figs. 3 and 4) than for
NY 3000 (Wibe et al., 1978).
Madoc-Jones & Mauro (1968) have
demonstrated that the interphase pro-
longation in HeLa cells after treatment
with high concentrations of the 2 spindle
inhibitors vincristine and vinblastine
appears in G2. The G2 prolongation was
induced only when the drug was present
in this phase. This G2-specific interphase
prolongation due to treatment with vin-
cristine has been confirmed in our labora-
tory, working with NHIK 3025 cells
(Wibe etal., 1978). Although a considerable
portion of the interphase prolongation
induced by NY 3170 treatment seems to
appear in late S and G2, the inhibitory
effect during interphase is not as phase-
specific as that of vincristine and vin-
blastine. Moreover, the data in Fig. 8
show no interphase prolongation when
NY 3170 is added in G2 (15 h), which
indicates that the interphase prolongation
after NY 3170 is virtually induced before
the onset of G2. This is confirmed by the
data in Fig. 5A. Consequently, the mode
of action of NY 3170 outside mitosis is
different from that of the clinically em-
ployed mitotic inhibitors vincristine and
vinblastine.
The inhibitory effects demonstrated in
the present report are generally reversible,
and not due to cytotoxic effects. However,
when NHIK 3025 cells are kept in
metaphase for several hours by inducing
protracted metaphase block, cell inactiva-
tion is found. Such inactivating effects of
NY 3170, measured as loss of colony-
forming ability, will be presented in
another paper (Wibe & Oftebro,inprepara-
tion).
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